Insiders · Profile

DEMAREE JOHN

Chief Commercial Officer at Karyopharm Therapeutics. Filing since 26 Aug 2020. CIK 0001744959

Company

Date

Role

Action

Amount

Of holding

26 Aug 2020

Chief Commercial Officer

Bought

7,500

$109.01K

opened

1 decision on file.